A diagnostic test for cancer was approved by the US Food and Drug Administration on 30 September which will help physicians detect hundreds of genetic variants associated with a person’s elevated risk of developing certain malignancies. Produced by Invitae Corp, the test also identifies potentially cancer-associated hereditary variants in individuals who have already been diagnosed with cancer.
